title: Mineralocorticoid receptor antagonists: part of an emerging treatment paradigm for chronic kidney disease.
authors.affiliation: Division of Nephrology and Hypertension, University of Miami, Leonard M. Miller School of Medicine, Miami, FL 33101, USA. murraye@gate.net
authors.forename: Murray
authors.initials: M
authors.lastname: Epstein
mesh_terms: D000419:Albuminuria / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D020011:Protective Agents / Q000627:therapeutic use*; D013148:Spironolactone / Q000031:analogs & derivatives*
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D020011:Protective Agents; D013148:Spironolactone